James C. Gahn
James C. Gahn publishes mostly in Endocrinology, Diabetes and Metabolism, Rheumatology and Economics and Econometrics, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Health Systems, Economic Evaluations, Quality of Life.
- World rank
- #4,451,585 of 7,710,434 ranked researchers
- Rank in United States
- #1,187,166 of 1,627,098
- Works
- 20
- Citations
- 204
- Citations per work
- 10.2
What does James C. Gahn research?
James C. Gahn's work is mostly in Medicine (58%), Economics, Econometrics and Finance (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1258.5%
- Medicine1258.5%
- Everything else632.1%
- Social Sciences29.4%
- 1Endocrinology, Diabetes and Metabolism26% of their works
- 2Rheumatology13% of their works
- 3Economics and Econometrics9% of their works
- 4Cardiology and Cardiovascular Medicine8% of their works
- 5Psychiatry and Mental health6% of their works
- 6Nephrology6% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Health Systems, Economic Evaluations, Quality of Life
- Blood Pressure and Hypertension Studies
- Thyroid Disorders and Treatments
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Gout, Hyperuricemia, Uric Acid
- Multiple Sclerosis Research Studies
Which keywords describe James C. Gahn's research?
The keywords of their largest research topics: Cardiovascular Disease, Glycemic Control, Insulin Therapy, Diabetes, Clinical Guidelines, Continuous Glucose Monitoring, Hypoglycemia and Cardiovascular Outcomes.
- Uric Acid
- Thyroid Dysfunction
- Multiple Sclerosis
- Hyperuricemia
- Blood Pressure
- Quality of Life
- Type 2 Diabetes
- Hypertension
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Diabetes
- Glycemic Control
- Cardiovascular Disease
- Insulin Therapy
- Clinical Guidelines
- Hypoglycemia
- Cardiovascular Risk
- Metabolic Syndrome
- Cost-effectiveness Analysis
- Antihypertensive Drugs
- Diagnostic Criteria
- Insulin Resistance
- Obesity
- Thyroid Hormone
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Cardiovascular Disease103 topics
- Glycemic Control102 topics
- Insulin Therapy102 topics
- Diabetes82 topics
- Clinical Guidelines62 topics
- Continuous Glucose Monitoring61 topic
- Hypoglycemia61 topic
- Cardiovascular Outcomes41 topic
- Cardiovascular Risk42 topics
- Hypertension42 topics
- Metabolic Syndrome42 topics
- Type 2 Diabetes41 topic
- Cost-effectiveness Analysis31 topic
- Quality of Life31 topic
- Antihypertensive Drugs21 topic
- Blood Pressure21 topic
- Diagnostic Criteria21 topic
- Hyperuricemia21 topic
- Insulin Resistance21 topic
- Multiple Sclerosis21 topic
- Obesity21 topic
- Thyroid Dysfunction21 topic
- Thyroid Hormone21 topic
- Uric Acid21 topic
Where does James C. Gahn work?
James C. Gahn's main affiliation in the publication record is Medical Decision Modeling (United States), United States.
How many publications and citations does James C. Gahn have?
OpenAlex counts 20 works and 204 citations for James C. Gahn, an h-index of 7, ranking #4,451,585 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James C. Gahn. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.